Skip to main content
Top

Drugs

Issue 11/2021

Content (11 Articles)

Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors

Marc Evans, Angharad R. Morgan, Zaheer Yousef, Gethin Ellis, Umesh Dashora, Dipesh C. Patel, Pam Brown, Wasim Hanif, Johnathan N. Townend, Naresh Kanumilli, Jim Moore, John P. H. Wilding, Stephen C. Bain

Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients

Lucien Roulet, Victoria Rollason, Jules Desmeules, Valérie Piguet

Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists

Jeffrey Gilreath, Mimi Lo, Joseph Bubalo

Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review

Marc-Alexandre Duceppe, Salmaan Kanji, Anh Thu Do, Ni Ruo, Yiorgos Alexandros Cavayas, Martin Albert, Maxime Robert-Halabi, Samara Zavalkoff, Patrice Dupont, Gordan Samoukovic, David R. Williamson

Pamiparib: First Approval

Anthony Markham

Amivantamab: First Approval

  • NSCLC
  • AdisInsight Report

Yahiya Y. Syed

Infigratinib: First Approval

Connie Kang

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images